| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/22/2004 | US20040077708 Atorvastatin calcium; bioavailability |
| 04/22/2004 | US20040077706 Piperidine and azepine derivatives; anxiolytic, analgesic, antidepressant, antiemetic, antiinflammatory, and hypotensive agents; sexual and psychological disorders; Alzheimer*s, Parkinson*s, Lesche-Nyhane, Wilson*s, and Tourette*s syndrome |
| 04/22/2004 | US20040077705 Cyclopentyl indole derivatives |
| 04/22/2004 | US20040077704 Fused cyclopenta-, cyclohexa-, or cyclohepta(g)indole derivatives as human non-pancreatic secretory phospholipase inhibitors; antiinflammatory agents |
| 04/22/2004 | US20040077703 Nodulisporic acid derivative spot-on formulations for combating parasites |
| 04/22/2004 | US20040077702 Administering indazole derivative; or thienyl-, furyl-, or pyrrolyl- fused pyrazole derivative to treat Alzheimer*s, Parkinson*s, or Huntington*s disease |
| 04/22/2004 | US20040077701 Pyrazole derivates for treatment of osteoporosis, breast and endometrial cancers, atherosclerosis, and Alzheimer*s disease |
| 04/22/2004 | US20040077699 Substituted triazole diamine derivatives as kinase inhibitors |
| 04/22/2004 | US20040077698 Tricyclic lactam and sultam derivatives and their use as histone deacetylase inhibitors |
| 04/22/2004 | US20040077697 2-Acylaminothiazole derivative or its salt |
| 04/22/2004 | US20040077696 Heterocyclic inhibitors of kinases |
| 04/22/2004 | US20040077695 Anticarcinogenic, antiallergen, and antiinflammatory agents; autoimmuned diseases |
| 04/22/2004 | US20040077694 Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 04/22/2004 | US20040077693 Integrin receptor inhibitors |
| 04/22/2004 | US20040077691 Hydroxamate derivatives of non-steroidal anti-inflammatory drugs |
| 04/22/2004 | US20040077689 Abc expression promoters |
| 04/22/2004 | US20040077688 Treating psoriasis, gastroesophageal reflux, Zollinger-Ellison Syndrome; antiulcer and antisecretory agents |
| 04/22/2004 | US20040077687 Thiazolmines and their use as tgf-beta inhibitors |
| 04/22/2004 | US20040077686 Inhibition of cyclooxygenase-2 activity |
| 04/22/2004 | US20040077685 Analogs of thalidomide as potential angiogenesis inhibitors |
| 04/22/2004 | US20040077684 Piperidinyl compounds that selectively bind integrins |
| 04/22/2004 | US20040077681 Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors |
| 04/22/2004 | US20040077680 Ureaacylated indazole, benzisoxazole, or benzisothiazole derivative with monocyte chemoattractant protein inhibitors; antiinflammatory agents; autoimmune diseases; arthritis, asthma, atherosclerosis, diabetes |
| 04/22/2004 | US20040077679 Obesity, insulin resistance, dyslipidemia; hypotensive agents; administering dopaminergic agent and agent that decreases noradrenergic neuronal activity |
| 04/22/2004 | US20040077678 Urea substituted imidazoquinoline ethers |
| 04/22/2004 | US20040077677 Oral formulations |
| 04/22/2004 | US20040077676 Neurotrophic tacrolimus analogs |
| 04/22/2004 | US20040077672 Anticarcinogenic, antiproliferative, and antitumor agents |
| 04/22/2004 | US20040077671 Sorbitol dehydrogenase inhibitors |
| 04/22/2004 | US20040077670 Novel sulfamides and their use as endothelin receptor antagonists |
| 04/22/2004 | US20040077668 Compounds, compositins, and methods |
| 04/22/2004 | US20040077667 Quinazolinone derivatives |
| 04/22/2004 | US20040077665 Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof |
| 04/22/2004 | US20040077664 Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates |
| 04/22/2004 | US20040077663 Thienopyrimidine-based inhibitors of the src family |
| 04/22/2004 | US20040077662 Compounds, methods and compositions |
| 04/22/2004 | US20040077661 Treatment of tuberous sclerosis associated neoplasms |
| 04/22/2004 | US20040077660 Method for treating insulin resistance, abdominal obesity, hypertension, hyperinsulinemia, and elevated blood lipids with a cortisol inhibitor |
| 04/22/2004 | US20040077659 2-(4-(((4-((4-(4-Oxyphenyl)-1-piperazinyl)methyl)-2-(4 -(trifluoromethyl)phenyl)-1,3-thiazol-5-yl)methyl)sulfanyl) phenoxy)2-methylpropanoic acid derivative administered as antidiabetic agent |
| 04/22/2004 | US20040077658 Respiratory system, nervous system, brain, gastrointestinal and psychological disorders; chronic obstructive pulmonary disease; antiasthmatics, analgesics |
| 04/22/2004 | US20040077657 HT3 Receptor antagonists; amyotrophic lateral sclerosis, premenstrual tension, obsessive-compulsive disorder; Parkinson*s, Alzheimer*s, and Huntington*s disease; memory, eating, psychological, and nervous system disorders |
| 04/22/2004 | US20040077656 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agents |
| 04/22/2004 | US20040077655 Piperazine derivatives for treatment of bacterial infections |
| 04/22/2004 | US20040077654 Anticholesterol agents; cardiovascular disorders |
| 04/22/2004 | US20040077653 GABAA (gamma-aminobutyric acid) receptor modulators; anxiolytic, antidepresant agents; attention deficit disorder, Alzheimer*s disease treatment; central nervous systmem disorders |
| 04/22/2004 | US20040077651 Fused N-heterocycle compounds as type-X sPLA2 (secretary PLA2) inhibitors; anticarcinogenic agents |
| 04/22/2004 | US20040077649 Novel cannabimimetic ligands |
| 04/22/2004 | US20040077648 Antiproliferative agents for smooth muscle cells; antiinflammatory agents for endothelial cells; restenosis, atherosclerosis |
| 04/22/2004 | US20040077645 Xanthine derivatives,production and use thereof as medicament |
| 04/22/2004 | US20040077644 Administering quinoline derivative as analgesic |
| 04/22/2004 | US20040077643 3,4 Dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 04/22/2004 | US20040077642 Pyrimidine compounds |
| 04/22/2004 | US20040077640 Sodium channel modulators derived from 2-piperidylimidazoles |
| 04/22/2004 | US20040077639 Administering amidine derivative as antiasthmatic agents; chronic obstructive pulmonary disease treatment |
| 04/22/2004 | US20040077637 Lorazepam, diphenhydramine, promethazine, and metoclopramide; oral or parental administering of neuroreceptor antagonists |
| 04/22/2004 | US20040077636 Administering alpha-2 adrenergic receptor agonists including guanabenz, clonidine, lofexidine, and/or salt; preventing stress-induced seeking of ethanol or nicotine; drug abuse, drug dependence |
| 04/22/2004 | US20040077634 Treatment of diseases characterized by excessive or insufficient cell death |
| 04/22/2004 | US20040077633 N-Heterocyclic derivatives; picornavirus infections in mammals; human rhinovirus |
| 04/22/2004 | US20040077632 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases |
| 04/22/2004 | US20040077630 Allosteric adenosine receptor modulators |
| 04/22/2004 | US20040077629 Such as 4-methyl-2-hydroxy-2-(4-hydroxy-4-methylpentyl)-butanediocate ester cephalotaxine derivative |
| 04/22/2004 | US20040077627 Crystalline (N)-(2-hydroxy-3-methyl-butyryl)-1-(alaninyl)-1-amino-3-methyl-4,5,6,7 -tetrahydro-2H-3-benzazepin-2-one anhydrate; inhibiting beta-amyloid peptide release and/or synthesis |
| 04/22/2004 | US20040077626 In vivo stability; very low metabolism rate |
| 04/22/2004 | US20040077624 Novel combination |
| 04/22/2004 | US20040077622 penicillins and oxapenicillins with a fused bicyclic N-heteroarymethylene group; 6-[(5-benzyl-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl)methylene]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; antibiotic resistance is reduced when administered alone or with other B-lactam antibiotics |
| 04/22/2004 | US20040077621 Antioxidants |
| 04/22/2004 | US20040077620 Hypoglycemic agent |
| 04/22/2004 | US20040077619 Calcium receptor modulating agents |
| 04/22/2004 | US20040077618 Epilepsy, bipolar disorder, psychiatric disorders, migraine, pain, neuroprotection, movement disorders; 2-methylcyclohexanecarboxamide, or 1,1':1',1''-ter(cyclopropane)-2'-carboxamide, or (cis)(2S)-2-((((3R,5S)-3,5-dimethylcyclohexyl) carbonyl)amino)propanoic acid for example |
| 04/22/2004 | US20040077617 for example 3-methylbicyclo[4.1.0]heptane-7-carboxylic acid or N-(2-amino-2-oxoethyl)-4,7,7-trimethyltricyclo [4.1.1.02,4]octane-3-carboxamide; use treating epilepsy, bipolar disorder, migraine, neuropathic and inflammatory pain |
| 04/22/2004 | US20040077615 Novel formulations for administering therapeutic lipophilic molecules |
| 04/22/2004 | US20040077614 High, sustained blood concentration levels even during pregnacy without hepatic side effects; 3,17-dipropionate or dihexanoate; multiple sclerosis |
| 04/22/2004 | US20040077613 Stimulation of preadipocyte differentiation; insulin resis-tance syndrome, dyslipidemia, type 2 diabetes; LXR alpha receptor agonists |
| 04/22/2004 | US20040077612 Acting as prodrugs; higher concentration delivery of active material to target cell in hybrid form; decreasing side effects |
| 04/22/2004 | US20040077611 Triple therapy of angiotensin converting enzyme inhibitor epoxy-steroidal aldosterone antagonist and diuretic or digoxin for treatment of cardiovascular disease |
| 04/22/2004 | US20040077610 Medicament containing a polyamine as an active substance |
| 04/22/2004 | US20040077609 Nonsteroidal antiinflammatory agent (NSAID), thymol, methyl salicylate, menthol and eucalyptol; gingivitis, halitosis |
| 04/22/2004 | US20040077608 Glyphosate formulations and their use for the inhibition of 5-enolpyruvylshikimate-3-phosphate synthase |
| 04/22/2004 | US20040077607 1-Furan-2-yl-1,2,3,4-tetrahydro-pyrimidine-2,4-dione and amino acid functionalized |
| 04/22/2004 | US20040077606 Anticancer, antiangiogenic agents; such as imidazo(1,5-a)-pyrazine-1,3-dione derivatives |
| 04/22/2004 | US20040077605 Cancer, immune disorders; such as 6-hydroxy-4-methyl-1,3-dioxo-4,7-epoxy-2H-isoindol-2-yl)-2-(trifluoromethyl)-benzonitrile |
| 04/22/2004 | US20040077604 Reducing toxicity of nonsteroidal antiinflammatory drugs (NSAIDs) |
| 04/22/2004 | US20040077601 Methods and compositions relating to isoleucine boroproline compounds |
| 04/22/2004 | US20040077600 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease |
| 04/22/2004 | US20040077598 Copolymer containing aminofunctionalized alkoxysiloxane monomer; slowing abnormal cell growth and proliferation while increasing death rate |
| 04/22/2004 | US20040077596 Use of n-acetyl-d-glucosamine in the manufacture of pharmaceutical useful for suppressing side-effect of radiotherapy and chemotherapy |
| 04/22/2004 | US20040077595 Cyclodextrin-based polymers for therapeutics delivery |
| 04/22/2004 | US20040077594 Included in cyclodextrin derivative; reducing irritation at intramuscular injection site |
| 04/22/2004 | US20040077593 Numbing gel for hair removal |
| 04/22/2004 | US20040077591 Ameliorating physical disability in animal models; preserva-tion of body weight, reduced atrophy and weakness, extended survival |
| 04/22/2004 | US20040077590 Use of soluble monovalent oligosaccharides as inhibitors of HIV-1 fusion and replication |
| 04/22/2004 | US20040077589 Treatment method against side-effects of chemotherapy |
| 04/22/2004 | US20040077587 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
| 04/22/2004 | US20040077585 Using P2Y receptor agonists with enhanced resistance to extracellular hydrolysis; such as dinucleoside polyphosphate compounds |
| 04/22/2004 | US20040077577 Gene therapy; vaccines; inducing antibodies and/or cytotoxic or helper T lymphocytes |
| 04/22/2004 | US20040077566 Methods and compositions for the treatment and diagnosis of body weight disorders |
| 04/22/2004 | US20040077564 Ring expanded nucleosides and nucleotides |
| 04/22/2004 | US20040077563 Uninhibited transport of such as 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamidine |
| 04/22/2004 | US20040077561 Using 4-desacetyl-4-methylcarbonate taxol with doxorubicin; does not stimulate formation of cardiotoxic metabolic by products |
| 04/22/2004 | US20040077560 Injectable ready-to-use solutions containing an antitumor anthracycline glycoside |